Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Cheng-Feng Qin and Yongqiang Deng.
Connection Strength

2.457
  1. Intranasal infection and contact transmission of Zika virus in guinea pigs. Nat Commun. 2017 11 21; 8(1):1648.
    View in: PubMed
    Score: 0.743
  2. SARS-CoV-2 infection in the mouse olfactory system. Cell Discov. 2021 Jul 06; 7(1):49.
    View in: PubMed
    Score: 0.239
  3. A single residue in the aB helix of the E protein is critical for Zika virus thermostability. Emerg Microbes Infect. 2018 01 24; 7(1):5.
    View in: PubMed
    Score: 0.188
  4. Phylogenetic and genetic characterization of a 2017 clinical isolate of H7N9 virus in Guangzhou, China during the fifth epidemic wave. Sci China Life Sci. 2017 12; 60(12):1331-1339.
    View in: PubMed
    Score: 0.184
  5. A single mutation in the prM protein of Zika virus contributes to fetal microcephaly. Science. 2017 11 17; 358(6365):933-936.
    View in: PubMed
    Score: 0.184
  6. Immunization with truncated envelope protein of Zika virus induces protective immune response in mice. Sci Rep. 2017 08 30; 7(1):10047.
    View in: PubMed
    Score: 0.183
  7. hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants. Cell Discov. 2021 Jul 20; 7(1):54.
    View in: PubMed
    Score: 0.060
  8. Proteome-wide epitope mapping identifies a resource of antibodies for SARS-CoV-2 detection and neutralization. Signal Transduct Target Ther. 2021 04 24; 6(1):166.
    View in: PubMed
    Score: 0.059
  9. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat Metab. 2020 12; 2(12):1391-1400.
    View in: PubMed
    Score: 0.057
  10. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science. 2020 09 25; 369(6511):1603-1607.
    View in: PubMed
    Score: 0.056
  11. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science. 2020 09 18; 369(6510):1505-1509.
    View in: PubMed
    Score: 0.056
  12. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells. Cell. 2020 07 09; 182(1):73-84.e16.
    View in: PubMed
    Score: 0.055
  13. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020 06; 582(7811):289-293.
    View in: PubMed
    Score: 0.055
  14. Structural basis for neutralization of Japanese encephalitis virus by two potent therapeutic antibodies. Nat Microbiol. 2018 03; 3(3):287-294.
    View in: PubMed
    Score: 0.047
  15. American Strain of Zika Virus Causes More Severe Microcephaly Than an Old Asian Strain in Neonatal Mice. EBioMedicine. 2017 Nov; 25:95-105.
    View in: PubMed
    Score: 0.046
  16. A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses. Nat Commun. 2017 07 25; 8:15672.
    View in: PubMed
    Score: 0.045
  17. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction. Cell Res. 2017 Aug; 27(8):1046-1064.
    View in: PubMed
    Score: 0.045
  18. Human Virus-Derived Small RNAs Can Confer Antiviral Immunity in Mammals. Immunity. 2017 06 20; 46(6):992-1004.e5.
    View in: PubMed
    Score: 0.045
  19. Vector competence and transovarial transmission of two Aedes aegypti strains to Zika virus. Emerg Microbes Infect. 2017 Apr 26; 6(4):e23.
    View in: PubMed
    Score: 0.045
  20. 25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model. Immunity. 2017 03 21; 46(3):446-456.
    View in: PubMed
    Score: 0.044
  21. [Construction of genomic full-length cDNA of SARS coronavirus BJ01 strain and identification of its biological characteristics]. Wei Sheng Wu Xue Bao. 2006 Dec; 46(6):922-7.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.